ASGCT Podcast Network Titelbild

ASGCT Podcast Network

ASGCT Podcast Network

Von: American Society of Gene & Cell Therapy
Jetzt kostenlos hören, ohne Abo

Nur 0,99 € pro Monat für die ersten 3 Monate

Danach 9.95 € pro Monat. Bedingungen gelten.

Über diesen Titel

The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.

Hygiene & gesundes Leben Wissenschaft
  • RNA interference gene therapy for Parkinson’s disease with Kathy Steece-Collier, Jeffrey Kordower, and Fredric Manfredsson
    Jan 8 2026

    Molecular Therapy Editor-in-Chief Dr. Joseph Glorioso joins researchers Kathy Steece-Collier (Michigan State University), Jeffrey Kordower (Arizona State University), and Fredric Manfredsson (Barrow Neurological Institute) to discuss their groundbreaking work on RNA interference for Parkinson’s disease. This episode focuses on their recent article titled "Disease-modifying, multidimensional efficacy of putaminal CaV1.3-shRNA gene therapy in aged parkinsonism male and female macaques."

    Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au

    Show your support for ASGCT!: https://asgct.org/membership/donate

    See omnystudio.com/listener for privacy information.

    Mehr anzeigen Weniger anzeigen
    45 Min.
  • The Issue - Entrepreneurship, Fundraising, and the Future of Cell & Gene Therapy with Dr. Niki Paulk
    Jan 6 2026

    Host Dr. Emily Walsh Martin welcomes Dr. Niki Paulk, CEO and Founder of Siren Biotechnology, for a timely conversation on turning scientific promise into commercial success. Dr. Paulk offers perceptive insights into the complex world of biotech entrepreneurship, covering essential fundraising strategies from Seed and Series Rounds to Community Rounds and beyond. This episode is a must-listen for both industry professionals and academic innovators.

    Music: ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. https://www.steven-obrien.net/

    Show your support for ASGCT!: https://asgct.org/membership/donate

    See omnystudio.com/listener for privacy information.

    Mehr anzeigen Weniger anzeigen
    57 Min.
  • The Issue - Unlocking New Therapeutic Potential: Ensoma’s Platform for Rare Disease and Oncology
    Dec 16 2025

    Host Emily Walsh Martin welcomes Dr. Jim Burns, CEO of Ensoma, to discuss the company's novel technological approach to treating both rare diseases and solid tumor oncology. Dr. Burns provides a detailed overview of Ensoma's platform and its application in their ongoing clinical trials, including the recently announced first patient infusion for Chronic granulomatous disease. Learn how this initial trial is set to inform future therapeutic opportunities for indications with high unmet medical need.

    Music: ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. https://www.steven-obrien.net/

    Show your support for ASGCT!: https://asgct.org/membership/donate

    See omnystudio.com/listener for privacy information.

    Mehr anzeigen Weniger anzeigen
    37 Min.
Noch keine Rezensionen vorhanden